Redefining Fertility Tracking with Innovative, Affordable Solutions

The journey toward parenthood fills many couples with excitement, hope, and anticipation. However, at the same time, conceiving a child can be a long, stressful battle full of frustration and uncertainty. Unknown to many, the struggle to conceive is not only about waiting for a positive pregnancy test. It involves months, if not years, of using traditional methods of tracking ovulation and regular doctor visits.  

Women are frequently left to rely on guesswork when pinpointing their most fertile days. Unfortunately, this process often leads to repeated disappointments, dashed hopes, and the constant pressure of time ticking away. Needless to say, the emotional toll can be immense for everyone involved. Couples feel lost, stressed, and unsure about the next steps to take.  

Premom, an innovative fertility app developed by the creators of Easy@Home, a best-selling ovulation test brand on Amazon, aims to empower women on their fertility journey. According to an article published by the National Institute of Health on PubMed: “Period tracker apps should ensure they only give women accurate information, especially for the day of ovulation and the fertile window which can only be predicted if using a marker of ovulation, such as basal body temperature, ovulation sticks or cervical mucus.”

Many other apps fail to offer accurate information, but Premom integrates ovulation tests, basal body temperature, and cervical mucus tracking. Most importantly, Premom’s free ovulation test reader provides quantitative readings that enable its advanced AI technology to be developed and continuously optimized based on a large-scale of data points. The same applies to its Bluetooth-connected basal temperature readings.   

Ovulation tests are a popular and effective method for women to track ovulation.  However, interpreting these tests accurately can sometimes be challenging. While many women may find multiple positive results even after ovulation, others may struggle to find a positive result at all, leading to uncertainty about the best time to conceive.  

Couples may opt for procedures like intrauterine insemination (IUI) or in vitro fertilization (IVF) in more complex cases. However, these assisted reproductive technologies (ART) often come with low success rates, side effects, and exorbitant costs. These factors make ART inaccessible for many families.  

The idea for Premom was born out of necessity. Sherry Liu and Li Zou, the creators of Premom, noticed that many women using their ovulation tests struggled to track their LH surge and pinpoint their fertile window accurately. Some women resorted to taping faded ovulation test strips into notebooks, trying in vain to figure out their hormone elevated pattern. 

The visionaries co-founded Premom in 2016 to create a more effective and user-friendly solution. After nearly two years of development, Premom was successfully launched, serving as a digital fertility tool for helping women track their ovulation in a smarter way.  

To achieve its mission of having the highest pregnancy success rate of any fertility app on the market, Premom has built an advanced AI-powered algorithm that delivers more accurate predictions of a woman’s fertile window. 

Premom’s digital ovulation test reader enables women to snap a photo of their ovulation test strip. This is then analyzed within the app to provide quantitative readings. They no longer need to manually interpret faded lines, offering users clear, quantitative results that highlight their low, high, and peak fertility days. One satisfied reviewer shares, “I have a relatively low LH peak level, so identifying my peak day was nearly impossible. The Premom app quickly reads my LH levels and stores them, which has been a tremendous help!” 

This smart charting makes it easier to visualize the best times for intercourse for optimal conception. Premom also integrates with a Bluetooth-enabled basal thermometer that syncs automatically with the app for accurate, data-driven insights. 

Premium members of the app can access detailed cycle reports created by physicians. These reports analyze each user’s unique cycle patterns, giving personalized recommendations for optimizing fertility. This is especially beneficial for women with irregular cycles.  

Premom also connects users with fertility specialists and pregnancy advisors through virtual consultations. For those who desire to share advice, ask questions, and celebrate victories, the app’s in-app community is a safe space where users can connect with others going through similar experiences.  

The app further supports users through its 9-Cycle Money-Back Guarantee Program. If a user cannot get pregnant within nine cycles, they’re eligible for a full refund on all Easy@Home or Premom ovulation and pregnancy test purchases. This initiative alleviates stress and financial burden, reflecting Premom’s dedication to providing actionable data and reducing uncertainty in fertility tracking. 

“Every step of our solutions has been designed with the user in mind, reflecting our commitment to making fertility tracking as simple, accessible, and stress-free as possible. Users can see this, from the affordability of our products to the accuracy of our app’s prediction. These efforts support our ultimate goal of empowering women with the information they need to take control of their fertility journey,” Liu emphasizes. 

As Premom continues to grow and expand its presence globally even after making inroads into over 100 countries, it remains focused on its core mission: helping women get pregnant quickly and naturally. It intends to increase awareness of fertility tracking solutions in regions like Central and South America, and India, where knowledge of ovulation and at-home fertility testing is still emerging. By extending its reach, Premom is bound to help millions more families on their fertility journeys. 

**This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider.